Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 20, Issue 2, 2006, Pages 193-205

  Goodarzi, Mark O ^a,b,c   Azziz, Ricardo ^b,c  

^a Medical Genetics Institute   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

complex disorders; epidemiology; phenotyping; polycystic ovary syndrome

Indexed keywords

ALDOSTERONE SYNTHASE; ANDROGEN; ANDROGEN RECEPTOR; AROMATASE; ARYLDIALKYLPHOSPHATASE; BLOOD CLOTTING FACTOR 5; CALPAIN 10; CYTOCHROME P450 17; DOPAMINE 3 RECEPTOR; FOLLISTATIN; FOLLITROPIN BETA SUBUNIT; FOLLITROPIN RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERSTITIAL COLLAGENASE; LUTEINIZING HORMONE BETA SUBUNIT; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN B; STEROID 21 MONOOXYGENASE; TUMOR NECROSIS FACTOR RECEPTOR 2;

AGE DISTRIBUTION; CHEMICAL PARAMETERS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; EPIDEMIOLOGICAL DATA; GENE IDENTIFICATION; GENETICS; HERITABILITY; HUMAN; HYPERANDROGENISM; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PREVALENCE; REVIEW;

ADOLESCENT; ADULT; EUROPE; FEMALE; HUMANS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PREVALENCE;

EID: 33744917014     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2006.02.005     Document Type: Review

References (57)

1. Stein I.F., and Leventhal N.L. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology 29 (1935) 181-191
2. Azziz R., Woods K.S., Reyna R., et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 2745-2749
3. Hull M.G. Ovulation failure and induction. Clinical Obstetrics and Gynaecology 8 (1981) 753-785
4. Legro R.S. The genetics of obesity. Lessons for polycystic ovary syndrome. Annals of the New York Academy of Sciences 900 (2000) 193-202
5. Azziz R. Androgen excess is the key element in the polycystic ovary syndrome. Fertility and Sterility 80 (2003) 252-254
6. Legro R.S., Kunselman A.R., and Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. The American Journal of Medicine 111 (2001) 607-613
7. Carmina E., Legro R.S., Stamets K., et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human Reproduction 18 (2003) 2289-2293
8. Azziz R., Sanchez L.A., Knochenhauer E.S., et al. Androgen excess in women: experience with over 1000 consecutive patients. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 453-462
9. Hahn S., Tan S., Elsenbruch S., et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in north Rhine-Westphalia. Hormone and Metabolic Research 37 (2005) 438-444
10. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
11. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 165-169
12. Carmina E., and Lobo R.A. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility 82 (2004) 661-665
13. DeUgarte C.M., Bartolucci A.A., and Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility 83 (2005) 1454-1460
14. Goodarzi M.O., and Korenman S.G. The importance of insulin resistance in polycystic ovary syndrome. Fertility and Sterility 80 (2003) 255-258
15. Rebar R., Judd H.L., Yen S.S.C., et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Journal of Clinical Investigation 57 (1976) 1320-1329
16. Conway G.S., Honour J.W., and Jacobs H.S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology (Oxford) 30 (1989) 459-470
17. Anttila L., Ding Y.-Q., Ruutiainen K., et al. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertility and Sterility 55 (1991) 1057-1061
18. van Santbrink E.J., Hop W.C., and Fauser B.C. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertility and Sterility 67 (1997) 452-458
19. Arroyo A., Laughlin G.A., Morales A.J., and Yen S.S. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 3728-3733
20. Taylor A.E., McCourt B., Martin K.A., et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 2248-2256
21. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F.P., and Merriam G.R. (Eds). Polycystic Ovary Syndrome (1992), Blackwell Scientific Publications, Boston 377-384
22. Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Human Reproduction 17 (2002) 2495-2499
23. The rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81 (2004) 19-25
24. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19 (2004) 41-47
25. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertility and Sterility 83 (2005) 1343-1346
26. Carmina E., and Lobo R.A. Polycystic ovaries in hirsute women with normal menses. The American Journal of Medicine 111 (2001) 602-606
27. Eden J.A., Place J., Carter G.D., et al. Is the polycystic ovary a cause of infertility in the ovulatory woman?. Clinical Endocrinology (Oxford) 30 (1989) 77-82
28. Kousta E., White D.M., Cela E., et al. The prevalence of polycystic ovaries in women with infertility. Human Reproduction 14 (1999) 2720-2723
29. Knochenhauer E.S., Key T.J., Kahsar-Miller M., et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 3078-3082
30. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 4006-4011
31. Asuncion M., Calvo R.M., San Millan J.L., et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 2434-2438
32. Michelmore K.F., Balen A.H., Dunger D.B., and Vessey M.P. Polycystic ovaries and associated clinical and biochemical features in young women. Clinical Endocrinology (Oxford) 51 (1999) 779-786
33. US census bureau. Census 2000 Summary File 1, QT-P3. http://factfinder.census.gov/servlet/DatasetMainPageServlet?_program=DEC&_lang=en
34. Hartz A.J., Barboriak P.N., Wong A., et al. The association of obesity with infertility and related menstrual abnormalities in women. International Journal of Obesity 3 (1979) 57-73
35. Heinonen S., Korhonen S., Hippelainen M., et al. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. American Journal of Obstetrics and Gynecology 184 (2001) 289-296
36. Escobar-Morreale H.F., Roldan B., Barrio R., et al. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 4182-4187
37. Conn J.J., Jacobs H.S., and Conway G.S. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clinical Endocrinology (Oxford) 52 (2000) 81-86
38. Peppard H.R., Marfori J., Iuorno M.J., and Nestler J.E. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 24 (2001) 1050-1052
39. Allen S.E., Potter H.D., and Azziz R. Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women. Fertility and Sterility 67 (1997) 569-572
40. Goodarzi M.O., Quiñones M.J., Azziz R., et al. Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertility and Sterility 84 (2005) 766-769
41. King R.A., Rotter J.I., and Motulsky A.G. The Genetic Basis of Common Diseases. 2nd edn (2002), Oxford University Press, New York
42. Legro R.S., and Strauss J.F. Molecular progress in infertility: polycystic ovary syndrome. Fertility and Sterility 78 (2002) 569-576
43. Kahsar-Miller M.D., Nixon C., Boots L.R., et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility 75 (2001) 53-58
44. Legro R.S., Driscoll D., Strauss III J.F., et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proceedings of the National Academy of Sciences of the USA 95 (1998) 14956-14960
45. Legro R.S., Kunselman A.R., Demers L., et al. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 2134-2138
46. Legro R.S., Bentley-Lewis R., Driscoll D., et al. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 2128-2133
47. Norman R.J., Masters S., and Hague W. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertility and Sterility 66 (1996) 942-947
48. Yildiz B.O., Yarali H., Oguz H., and Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first-degree relatives of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 2031-2036
49. Kaushal R., Parchure N., Bano G., et al. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clinical Endocrinology (Oxford) 60 (2004) 322-328
50. Colilla S., Cox N.J., and Ehrmann D.A. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first-degree relatives. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 2027-2031
51. Ehrmann D.A., Sturis J., Byrne M.M., et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 96 (1995) 520-527
52. Nelson V.L., Legro R.S., Strauss J.F., and McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology 13 (1999) 946-957
53. Dunaif A., Wu X., Lee A., and Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). American Journal of Physiology Endocrinology and Metabolism 281 (2001) E392-E399
54. Rosenbaum D., Haber R.S., and Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. American Journal of Physiology 264 (1993) E197-E202
55. Ciaraldi T.P., el-Roeiy A., Madar Z., et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. The Journal of Clinical Endocrinology and Metabolism 75 (1992) 577-583
56. Escobar-Morreale H.F., Luque-Ramirez M., and San Millan J.L. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews 26 (2005) 251-282
57. Parikh H., and Groop L. Candidate genes for type 2 diabetes. Reviews in Endocrine and Metabolic Disorders 5 (2004) 151-176